Top Healthcare & Digital Health Investors 2026

Rock Health Capital invests in remarkable entrepreneurs working at the intersection of healthcare and technology to make healthcare massively better for every human being. We combine deep healthcare expertise with venture capital discipline and leverage the Rock Health platform to provide portfolio companies with market insights, community access, and strategic support.

Elite technical founders solving critical healthcare problems at the earliest stages create transformative solutions. We partner with founders who deeply understand healthcare inefficiencies and modern technology, providing capital, strategic guidance, and operational support.

The best health-tech companies are built by founders who have previously started and scaled healthcare companies and understand the operational complexity of healthcare delivery. We partner with repeat founders solving real healthcare problems with direct impact on patient outcomes, especially for underserved populations. Our 22 venture partners and 114 investor network provide unmatched access to healthcare system leaders, policymakers, and go-to-market expertise.

Breakthrough healthcare innovations must serve women and underrepresented populations. AI-driven healthcare solutions unlock new markets and address systemic health inequities. Women's health is severely underfunded and represents major opportunity to drive both returns and health impact.

Digital health startups need experienced champions who can guide them through scaling challenges. We partner with founders to identify and fund disruptive innovations that improve diagnosis rates, develop new treatments, and boost wellbeing worldwide. The digital health market has grown 150% since 2017 and represents a massive opportunity to build companies that are both financially successful and socially impactful.

We invest exclusively in early-stage digital health companies leveraging technology, data, and digital therapeutics to solve healthcare inefficiencies. Our focus is on data-driven solutions that generate competitive insights and enhance patient outcomes.

Data-driven technologies that transform the cancer care journey end-to-end: from early detection and precision diagnostics, to care navigation and survivorship, and the non-drug infrastructure that makes treatment work in the real world. The $210B+ US oncology market is fragmented and evidence-based care is chronically underdelivered — technology can close this gap while reducing costs.

Double bottom-line venture capital focused on advancing health equity for diverse and underserved populations. We invest in early-stage healthcare solutions that meaningfully address healthcare disparities, improve access to care, and reduce inequality—while achieving commercial success.

Digital innovation transforms healthcare delivery. We invest in technologies efficiently driving value-based patient outcomes through convenient, seamless experiences. Our patient-first approach is core to all investments.

Back exceptional inventors building their own enduring businesses in life sciences. Founders who design the initial conditions of a company have superior odds of creating transformative value.

Healthcare's largest markets are ripe for disruption through software-first solutions. We back companies advancing care delivery through new technologies and care models, and software-first techbio platforms that transform drug discovery and therapeutic development.

Healthcare innovation that transforms care delivery, improves patient outcomes, and creates sustainable economic value for the healthcare system. FCV partners with founder-operators who combine clinical/healthcare expertise with operational excellence to build national-scale solutions addressing critical healthcare inefficiencies and access gaps.

Healthcare technology companies that improve patient care, reduce costs, streamline operations, and reshape healthcare delivery will define the future of healthcare. We partner with experienced founding teams to build thriving businesses across providers, payers, pharma, and innovative care delivery models.

Transforming disruptive European academic research into innovative therapeutics and diagnostics for severe diseases with high unmet medical needs. Operates as a venture builder, co-founding companies ex-nihilo from scientific discoveries and backing established venture-stage biotechs.

Funds founders elevating brain and mental health through neuroscience, frontier technologies, psychedelic medicine, precision neuroscience, neurotechnology, AI-enabled diagnosis and treatment, novel CNS therapeutics, digital health, and related modalities.

We invest in people solving difficult problems and building category-defining products in healthcare. We partner with visionary leaders at the intersection of medical technology and digital health to create transformative solutions that improve patient outcomes.

Invest in founders building transformative healthcare solutions with AI and tech. Combine venture capital with operational expertise and direct access to $50B+ health system (LifePoint Health) for pilot deployment, real-world validation, and market expansion opportunities. Focus on category-defining startups that improve healthcare operations, patient outcomes, and access to care.

Invest in early-stage digital health companies that empower informed, connected health consumers to make confident decisions about their health. Focus on removing friction from healthcare, providing transparency, and enabling people to take control of their health journey through technology. Particular emphasis on solving structural problems in chronic disease management, mental health, reproductive health, aging in place, and specialty care navigation.

CVS Health Ventures invests in healthcare innovators that make care simpler, more accessible, and more affordable. The fund leverages CVS Health's national footprint — 9,000+ pharmacies, MinuteClinics, Aetna, and Oak Street Health — as a strategic distribution channel and operating partner for portfolio companies. Key focus areas: tech-enabled clinical workflows, disruptive care models, whole-person health, and consumer-centric experiences.

Inflect Health invests in visionary entrepreneurs building category-defining solutions to transform healthcare. Unlike traditional VCs, Inflect's success metric balances financial returns with health outcomes improvement. We back founders with clear vision, diverse teams, and passion for healthcare transformation. Our physician-led partnership brings 45+ years of healthcare operational expertise and direct access to 8,000+ clinicians, enabling hands-on partnership from design through go-to-market.

Deep health emerges at the convergence of advances in biology, chemistry, AI/ML, robotics, and clinical medicine. We back visionary founders addressing root causes of chronic disease across three domains: biology within us (biotech platforms), environment around us (environmental/chemical health), and systems that care for us (healthcare delivery innovation).

Fund and build next-generation life sciences companies solving important healthcare needs through cutting-edge breakthroughs in medicine and science. Partner closely with management teams to maximize returns across all portfolio companies through hands-on operational support, strategic guidance, and access to networks of experienced life science leaders.

We invest with patient, long-term capital in proven management teams and entrepreneurs building differentiated healthcare and tech-enabled businesses with recurring revenue models. Our permanent capital base gives us flexibility to support portfolio companies through their entire lifecycle.

Talented early-stage biotech founders need patient capital and experienced mentorship to navigate the intersection of genomics and data science. We provide both financial support and hands-on operational guidance from day one.

Healthcare is one of the most compelling long-term investment opportunities globally, driven by aging demographics, rising healthcare spending, and continuous scientific innovation. We invest across the entire healthcare value chain to drive innovation and address unmet medical needs.

Breakthrough science merged with operational rigor creates transformational opportunities in life sciences. We identify emerging fields at the intersection of science and unmet medical need, then actively shape company formation working with scientific founders and expert advisors to design strategy from inception.

Early-stage companies leveraging frontier technologies (AI, gene editing, synthetic biology, advanced diagnostics) to transform human health, cure disease, and strengthen global resilience. Data-driven, engineering-first approaches combined with cellular biology create transformative healthcare companies. Focus on companies that solve problems affecting everyday people globally with platform potential across multiple indications and therapeutic pathways.

Translating groundbreaking science into life-changing medicines through seed-led investment model emphasizing science-first, patient-centric, collaborative approach. Play the long game with urgency - combining patient discipline with speed to market.

Partner with exceptional founders solving critical healthcare challenges and building enterprise infrastructure from inception through IPO. Combine venture capital with 30+ years of operational expertise and capital resources from Maverick Capital.

Healthcare innovation is a team sport. We identify promising healthcare technologies early in their life cycle and invest much more than capital to help our teams become world-class enterprises. We provide clinical expertise, operational guidance, and network access from a team of practicing physicians and healthcare operators.

AI-native startups led by visionary founders redefining global industries. 10x Solutions, Not 10% Improvements. Operator-led partners who have built and scaled companies, bringing hands-on mentorship and network access.

Women-led companies outperform male-led peers financially while using less capital. True Wealth Ventures combines gender-lens investing with impact focus, exclusively backing women-led companies improving environmental and/or human health. This unlocks superior returns while creating measurable social impact.

Back healthcare disruptors—entrepreneurs who recognize how the industry is transforming and want to make meaningful impact. Focus on health-tech innovation excluding bio-pharma drug discovery. Leverage unique network of healthcare-industry insiders as limited partners.

Science-backed sleep solutions will dominate the market. We invest in innovative solutions across all sectors aimed at improving sleep, applying advanced sleep science to support portfolio companies.

Life sciences is experiencing unprecedented innovation through TechBio—companies that merge technology and biology. We partner with passionate, accomplished founders with unique insights to solve daring life science problems and significantly impact patient care. We provide capital, operational support, scientific guidance, and industry relationships to build transformative companies.

Back global-minded founders with cross-cultural perspectives and lived experience solving structural healthcare inequities. We invest at the intersection of clinical expertise and technical execution, deploying human capital, financial capital, and cultural capital to support founders building solutions that improve patient outcomes, lower costs, enhance patient and provider experience.

Building the future of healthy and active humanity. Wildwood builds and invests in early-stage consumer technology companies at the intersection of the outdoor and wellness economies, addressing America's health and wellness crisis for greater physical, mental, social and spiritual wellbeing.

Systematically back clinically rigorous, behaviorally grounded wellbeing startups tackling stigmatized areas—alcohol use disorder, menopause, mental health—using stigma as an investing edge and insisting on consumer-grade UX. Solve the Wellness Gap: the quantifiable delta that has grown as GDP per capita increased while physical and mental health stagnated.

We invest in founders reimagining education and human capital development globally. We are first believers in unconventional education models and invest particularly in early childhood, frontier markets, and founders with deep education domain expertise.

Invest in visionary technical founders building frontier healthcare solutions at the intersection of novel science and deep technology. Focus on 'hard problems' requiring scientific innovation and engineering excellence—neurotech, AI-driven biology, AR/VR medical applications, and novel care delivery models. Partner with founders (especially scientists and engineers from academia transitioning to entrepreneurship) who are fundamentally changing how healthcare works.

Investing in healthcare data companies tackling the biggest problems in cancer care — from early detection to patient navigation to data access and AI-powered treatment optimization. The U.S. oncology system is fragmented, expensive, and filled with barriers to evidence-based care. We fund the technologies that fix this.

The longevity economy is a massive addressable market. Companies transforming quality of life for aging adults will be highly profitable and impactful. Experienced founders over 50 solve aging problems better because they understand them firsthand.

Venture capital can do more than fund companies—it can create them from the ground up. Newpath Partners specializes in building biotechnology companies in partnership with leading academic scientists, focusing on breakthrough biology platforms in gene editing, regenerative medicine, and transformational therapeutics that address the greatest unmet medical needs.

Innovation in healthcare comes from all corners, particularly from founders with lived experience of healthcare inequities. We flip the traditional adoption model by backing diverse founders solving challenges at the intersection of digital health and social determinants of health. Helping marginalized populations first is both socially responsible and strategically sound.

We invest in companies intentionally closing gaps in wealth, health, and skills through our Inclusive Investing™ framework. Exceptional founders and transformative opportunities exist far beyond traditional VC hubs; we target overlooked founders building category-leading businesses with systemic impact.

Only invest where we have a true unfair advantage. Partner with founders in healthcare, data+AI, and cybersecurity to build category-defining powerhouses. We deliver value far beyond capital through deep domain expertise and extensive networks.

Co-found and build breakthrough life sciences and deep-science companies with university researchers. Follow science to create revolutionary technologies that prevent, detect, and cure disease. Patient capital from concept stage through commercialization.

Venture capital is the platform for future workflows, therapies, and leaders in US healthcare. We back exceptional founders who, when paired with strategic capital and engaged partnership, can transform healthcare by building valuable companies that lower costs, improve outcomes, and drive positive change.

Partner with exceptional healthcare entrepreneurs to build companies that improve outcomes and reduce clinical and administrative costs. Founders with deep healthcare industry experience and understanding of customer pain points can build transformative companies.

The best investment opportunities exist in markets everyone else ignores. We invest in inspirational founders building tech-enabled solutions addressing the social determinants of health and preventable drivers of chronic disease. Rather than traditional healthcare (sickcare), we invest in the Future of Health through preventative solutions and food security.

Back transformational healthcare companies at pre-seed through Series A that leverage technology to improve patient outcomes, healthcare operations, or clinical delivery. Partner with founders who understand both healthcare workflows and technology innovation deeply.

Breakthroughs at the convergence of technology, science, and humanity improve how we live, work, and experience the world. We invest in transformative technologies for human performance and wellbeing.

We invest in who you are, not just what you do. We back visionaries and game-changers with character and global ambition. We partner long-term with founders, providing capital, operational support, and deep conviction in their vision.

We are serial founders turned venture capitalists. We invest in market leaders building soon-to-be massive tech companies. Our approach focuses on long-term success, not short-term gains. We roll up our sleeves, get creative, lead with empathy, and have fun along the way.

Synthetic biology and life sciences are engineering disciplines. The world's greatest challenges in human and planetary health will be solved by scientists and engineers using biology as a tool. We fund the earliest-stage founders with breakthrough ideas and provide wet lab infrastructure, capital, and long-term partnership.

We help bold, creative, and humble founders build great companies by providing hands-on operational support, strategic guidance, and valuable ecosystem connections. We specialize in fintech, insurtech, digital health, and enterprise software where we can add deep value beyond capital.

The best healthcare solutions emerge from teams that deeply understand real-world clinical challenges. We embed 650+ clinicians as partners in deal sourcing, diligence, and portfolio support. Unlike traditional VCs, we connect founders with authentic practitioners who understand unglamorous but deeply human healthcare problems.

We help turn the best ideas in healthcare into category-defining companies. The best healthcare companies emerge from disciplined partnerships with visionary founders combining technical expertise with healthcare domain knowledge.

We seed high-growth startups with unstoppable drive in healthcare, fintech, and logistics. Founder does not have a stereotype—it is about drive, character, and conviction. We provide capital, operational support, and genuine partnership.

The greatest returns come from the most overlooked markets where businesses outperform because they create value. We invest in early-stage technology companies that unlock wealth and health for the mass market — in massively regulated, operationally complex sectors that are broken and overdue for reinvention: financial services, healthcare, real estate, insurance, and work.

We invest in proven operators reshaping essential industries. Our focus is on operator-founders who have deep scaling experience at companies like Uber, Flexport, and Northrop Grumman. We back First Builders—specialists and generalists who understand how to build and scale organizations.

Back B2B software founders solving real problems in sales, go-to-market, product, growth, and fundraising. We bring operational expertise from both founder and investor perspectives.

We invest in ideas and people first, then help build products. We believe connections are power and leverage an extensive network to support founders. We are founder-focused and work as trusted partners at the earliest stages.

Healthcare's future will be defined by the convergence of technology innovation, consumer preferences, and industry transformation. We partner with entrepreneurs who combine deep healthcare domain expertise with technical excellence to build category-defining companies.

Financial innovation drives transformation toward equitable, inclusive financial systems. We back fintech companies expanding access to financial services for underserved consumers and businesses in emerging markets. Impact and returns are complementary, not conflicting.

We back exceptional founders who elevate human potential and ignite purpose across learning, health, and work. When people are equipped to grow their skills, nurture relationships, be healthy, and find meaning in what they do, communities thrive.

Science-driven venture capital focused on breakthrough healthcare innovations. Deep scientific rigor in diligence with mechanism-of-action understanding, proof-of-concept validation, and extensive KOL/clinician engagement. Backed by Zambon Group pharmaceutical expertise.

We back underdogs that traditional VC has overlooked for too long. Founders with grit, capital efficiency, and non-traditional backgrounds who demonstrate exceptional execution capability and product-market fit.

Achieve strong investment returns by investing in EBITDA-positive, founder-led healthcare companies that improve healthcare delivery. Apply the CEO Council Model — 34 senior healthcare operators who have personally invested $140M+ — to unlock growth through relationships, strategic insights, and hands-on value creation.

Stanford's best entrepreneurs deserve equity-free, community-first support. We provide founders with world-class mentorship from 80+ tenured professors, access to a 3,000+ founder network, and long-term community support without dilution.

Long-term venture partnerships built on depth of thought, conviction, and dimensional thinking. We back founders with diverse lived experiences who are building transformative companies. We operate as a team sport—you don't work with individual partners, you work with Acrew. We invest in emotional intelligence, operational support, and the long arc of building meaningful companies.

Complex health problems require multidisciplinary teams combining deep technical, financial, and domain expertise. We invest in breakthrough science and technology-enabled solutions across human and animal health.

Civilization Ventures backs exceptional scientific founders—particularly PhDs and postdocs from elite institutions—building essential innovations in health tech and biology. We believe the best breakthroughs come from disruptive science combined with founder determination. We provide 'mentor capital': not just capital, but active operational guidance, scientific rigor, and access to our network of Fellows, Advisors, and portfolio founders.

Backs early-stage AgeTech, senior-care, digital-health, and technology-enabled services companies transforming the aging journey, using a senior-care operator and LP network to help with distribution, diligence, product feedback, talent, and go-to-market.

Longevity is a completely new industry within biotech requiring founders who can think differently. Mission-oriented, founder-led companies with unconventional backgrounds will prove most effective at bringing the first longevity drugs to market and extending human healthy lifespan. The field is at a critical inflection point where we will either breakthrough to mainstream or get silo'd in a funding winter.

Partner with founders to build and scale fintech businesses focused on profitability and capital efficiency. Target companies with clear paths to $50-250M strategic exits with demonstrated revenue and unit economics.

Back authentic founders building next-generation consumer brands across food, wellness, personal care, and pet. Combine early-stage capital with hands-on operational partnership and domain expertise to build enduring consumer brands and drive long-term value creation.

Risk becomes opportunity when paired with the right capital. Distributed Ventures invests in early-stage companies transforming health, insurance, and wealth through technology, partnering with founders to provide not just capital but strategic guidance, distribution channels, and operational expertise. The firm's unique LP base of insurance carriers, wealth managers, and brokers creates direct customer access and validation opportunities.

Create first-in-category bioplatform companies through scientific innovation and systematic entrepreneurship. Combine institutional scale with pioneer creativity to build breakthrough life sciences companies.

Artificial intelligence will reshape every industry. We partner with technical founders building the next generation of AI applications, infrastructure, and tools across every layer of the AI stack.

Passion and vision matter more than pedigree. We seek founders with grit, audacity, and a spark of rebellion—regardless of background. We invest early, before success is inevitable, and support founders from 0-to-1 through Series A.

Great companies are built by exceptional founders at the earliest stages. We believe in leading rounds from day one and providing lasting partnership through good times and bad.

Funding the next generation of contrarian founders building breakthrough longevity biotech companies. We invest in the transition from sickcare to healthcare by extending healthy lifespan and preventing age-related disease.

Invest in companies reimagining backbone sectors of the 21st century economy. Three focus areas: Food Technology (post-farmgate through foodservice), Digital Health & SaaS (democratizing quality care), and Enterprise SaaS (supply chain, commerce, core systems). Leverage Minnesota's unique ecosystem of Fortune 500 companies, medical innovation legacy, and deep industry networks.

Early-stage founders with innovative solutions in cybersecurity, healthcare technology, and physical security can be accelerated to scale with the right capital, strategic customer introductions, and operational guidance. Companies demonstrating early product-market fit through revenue, pilots, or design partnerships represent the best investment opportunities.

Partner with mission-oriented founders working on transformational ideas that use science and technology to improve human health and better humanity in lasting ways. We seek founders who bring deep technical expertise and commitment to solving complex scientific and healthcare challenges.

Consumer brands with founder-driven, product-driven companies and foundational growth strategies. Consumer infrastructure platforms enhancing supply chain, 3PL, inventory, analytics, and e-commerce. Creating a circular ecosystem where infrastructure and brand founders collaborate.

Intentional, thesis-driven early-stage investing in fintech, digital health, and AI. Focus on category-defining companies solving real customer problems with founders who understand their domain deeply. Emphasis on go-to-market strategy and execution discipline.

Technology and biology are converging to create the next generation of transformative companies. The digitization of life sciences—driven by exponential growth in biological data and advances in AI/ML—is enabling a new class of platform companies that will dominate the industry. Tomorrow's biotech will be built by teams of three: a biologist, a chemist, and a computer scientist.

Apply revolutionary biotechnology to replace industrial inputs with biology-based alternatives, transforming how the world manufactures chemicals, materials, foods, and medicines. Synthetic biology is a $25T opportunity spanning industrial inputs, food & agriculture, pharmaceuticals, and specialized applications.

Ecosystem-driven VC backing B2B companies transforming health, wealth, and work. The SemperSystem network of 200+ Fortune 500 buyers (ADP, Paychex, Cigna, MetLife, Unum) provides portfolio companies with enterprise GTM acceleration in complex regulated markets.

Partner with ambitious founders building category-winning companies. We believe great founders who understand execution, customer obsession, and operational excellence can build transformative companies. We provide capital, operational guidance, network access, and strategic partnership—not just funding.

We invest in companies that solve for non-consumption, plug infrastructural gaps and democratise prosperity in Africa, by eliminating the barriers to access and reducing the costs of delivering goods and services.

Technology can be a catalyst for positive change and progress. We back entrepreneurs building category-defining businesses regardless of their credentials or background. We are committed to democratizing venture capital access and supporting diverse founding teams across multiple sectors and geographies.

People make all the difference. We invest in great people building great businesses. Partnership-driven investments where we serve as true partners for the long term, not just financial backers. Our core belief is in 'paying it forward' - building lasting relationships with entrepreneurs.

AI-enabled companies building essential systems households depend on—across health, wealth, and climate resilience. Backs founders with earned secrets and lived proximity to the problems they solve, particularly serving the 99% in underserved communities.

Investing at the intersection of Invention & Culture. We back founders building category-defining consumer companies where technology breakthroughs meet emerging human behavior. We see inflection points before they're consensus by tracking both emerging technology capabilities and emerging consumer demands.

Mission-driven founders building transformative companies. FPV backs missionaries, not mercenaries—founders with genuine conviction in solving hard problems and willingness to pursue 100-year visions. Focus on founders who are misunderstood initially but recognized as geniuses for changing the world. Founder service is their North Star—they aim to be the founder's first phone call with operational support from experienced partners.

Invest in founders building radically different technology companies with unique business models or distribution strategies. Focus on high-velocity founders who are maniacs on a mission.

TheGP deploys experienced builders alongside capital to help founders achieve product-market fit faster. The firm's 25+ full-time builders—engineers, recruiters, designers, sales leaders—embed in portfolio companies for an average of nine months, earning equity grants tied to milestone delivery. This 'sweat equity' model creates deeper alignment than capital-only VC and is applied across Formation ($1-5M) and Breakout ($5-15M+) stages.

We invest in diverse leadership teams with the ability to create flywheel effects of growth in new markets. We focus on three core areas: Commerce (identifiable brands with data-driven opportunities), Care (tech-enabled health and wellness innovations), and Connectivity (platforms enhancing information expression and distribution). We believe women are not underfunded but untapped, and we're positioned at an inflection point in venture to elevate women to C-suite leadership roles.

We invest at the intersection of health, wealth, and privacy. The next generation of financial infrastructure, healthcare, and data security solutions will emerge from early-stage startups addressing this convergence. We partner with founders and leverage corporate LP relationships for distribution and go-to-market.

Contrarian venture firm investing in scientific and technical breakthroughs. We identify white-space opportunities where technical founders are solving previously unsolvable problems. We combine capital with deep domain expertise, research capabilities, and operational support to help founders scale from idea to commercialization.

We invest in startups building the technologies, infrastructure, and services that will be integral as we progress towards a Type I Civilization on the Kardashev Scale. Humanity is at ~Type 0.73 civilization and estimated to reach Type I in ~100 years. We fund moonshot technologies solving fundamental problems in space, robotics, AI, and human longevity.

Investing in 'Beautiful Software' — software where code architecture mirrors user intent so cleanly that complexity disappears. Backs founders with high 'motive force,' the internal drive that sustains motion through uncertainty. Believes beauty compounds: quality code attracts quality engineers, thoughtful design creates passionate users, and passionate users become evangelists.

We are second believers in the magically weird. We back founders at concept stage who are building unconventional solutions with bold personalities that challenge the status quo. We provide capital, community, and genuine support—acting as a bubbe to our founders.

Thematic-driven investor backing ambitious founders building for big outcomes across critical domains. Core conviction: defensible businesses create competitive advantages by transforming data challenges and market opportunities into sustainable value. We Go Deep, Not Wide. Focus on AI (defensible AI turns data challenges into advantages), Consumer (vision and strategy to break through attention economy), and Defense Tech (modern solutions for global stability). Active operational partnership beyond capital provision.

Tech for good - using technology to tackle big social and environmental problems while building commercially successful, scalable businesses. Purpose-driven value is not a trend but a paradigm shift.

Back founders with grit, industry insights, and strong engineering cultures to build amazing software that disrupts incumbents. Deliberately invest in unsexy industries and antiquated markets (warehousing, real estate, specialty pharmacy, agriculture) that others overlook, where nimble startups can create tremendous value.

Backing the most ambitious mission-driven founders building software and software-driven companies during the earliest days of company building. We seek non-consensus opportunities that solve today's biggest challenges across health, climate, and empowerment.

Ascend backs the most active pre-seed founders in the Pacific Northwest building SaaS 3.0 (vertical AI agents), Gen AI 2.0 (fast-follower infrastructure), and Frontier AI (AI applied to the physical world). Seattle has one in four of the U.S.'s AI engineers — Ascend captures that alpha as the first institutional check.

Backing transformative founders building exceptional companies across all sectors

Point72 Ventures backs ambitious founders building for big outcomes across critical domains. Going deep, not wide—the firm focuses on specialized investment theses in AI, Consumer, and Defense Tech, bringing deep sector insights, partnership, and hands-on support from seed to pre-IPO.

Breakthrough startups are designed futures, not lottery tickets. We back extraordinary founders with breakthrough insights before the world believes. We are co-conspirators, not just investors.

Patient capital for mission-driven innovation. We believe addressing major UK social and environmental challenges requires technology innovation funded with multi-decade horizons. Backed by National Lottery endowment, enabling long-term patient capital fundamentally different from traditional VC.

Back ambitious 'go-all-in' founders building defensible B2B software at pre-seed and seed, and support them intensively through the journey to Series A. Focus on AI, infrastructure, health, TechBio, open source, and marketplaces.

We specialize in consumer. We invest under the premise that value creation comes through identifying where consumer behavior is changing, especially before it's obvious. We are obsessed with observing how people live, work, learn, play, eat, and stay well. Often, we look at how technology and consumer centricity are disrupting archaic industries. We back the brave & curious, leaning into the non-obvious ideas that edit entire industries or create new categories.

Atinum Investment identifies and invests in companies solving fundamental problems through technology innovation and market disruption. The firm specializes in growth-stage startups and paradigm-shifting companies across diverse sectors.

Category-defining products that disrupt industry verticals by changing consumer behaviors and creating new markets. We fund digital commerce and consumer fintech businesses that demonstrate obsessive attention to customer experience.

Reshape venture capital by operating as true partners to founders. We seek founders with clarity of thought, a deep chip on their shoulder, and obsessive focus on solving problems they can't unsee. We provide not just capital but hands-on partnership, strategic guidance, and operator networks to guide breakthrough companies through product-market fit.

Invest in early-stage companies building transformative solutions in fintech, healthcare technology, and enterprise software with experienced, technical founders who have deep domain expertise.

Identifying culturally resonant, consumer-focused companies with differentiated products and founder teams that will capture global attention. We invest across technology, consumer behavior, entertainment, and culture—seeking to spot emerging trends before they reach mainstream awareness. We operate as a partnership combining rigorous deal selection with exceptional founder support, creative marketing, and deep understanding of consumer psychology.

We invest in people and give them freedom and support needed to execute their vision. We rely on data to measure, manage and monetize. We encourage bold ideas which are true, firm, confident, strong and resilient. We praise agility - the key to success in a competitive environment. We invest in early-stage companies operating with clear focus on sustainability in every dimension: business practices, unit economics and environmental impact.

Invest in people and products that leverage technological breakthroughs or superior user experience to radically change the status quo. Focus on structurally sound, strategically defensible business models that create and capture new markets. True partnership approach: value-add extends beyond capital to include strategic guidance, operational expertise, and network introductions.

The community-powered VC of the New Nordics. We invest in globally ambitious, impact-aware founders building companies that will solve the world's most pressing challenges. Superior financial returns come from responsible, impact-conscious investing that balances pure financial returns with positive social and environmental impact.

The Mountain West can produce world-class companies. We back exceptional founders solving real problems with strong product-market understanding. We provide capital, strategic network, operational support, and patient capital through multiple iterations.

We back belief-driven founders at the earliest stage with a clear understanding of their first winnable chapter. We combine capital with hands-on operational support to de-risk and accelerate ventures. Often the first institutional investors.

Patient Capital. True Resources. Big Impacts. S3 backs visionary founders building in Business Software and Healthcare Technology. Unique single-LP structure (a multi-billion dollar philanthropic family office) enables patient, flexible investing unconstrained by traditional VC fundraising cycles. Founded in Texas in 2005 — the largest and longest-serving VC native to Texas.

Bold B2B software entrepreneurs at Pre-Seed and Seed stages building transformational vertical AI applications, enterprise software, infrastructure, security, and fintech. Underscore employs an 'open-source' investing model sharing economics with their Core Community of operator-advisors who provide portfolio companies with world-class expertise at no cost.

Early-stage technology companies operating in highly regulated markets can achieve extraordinary growth when founders understand how to turn regulatory and political risk into a competitive advantage. We provide not just capital but also political expertise and government relations support to help solve the regulatory gating issues that unlock growth.

Blumberg Capital backs visionary teams as early and growth stage investors, active board members, and hands-on advisors. They invest in transformative technology companies across enterprise software, cybersecurity, fintech, healthcare tech, and AI with particular strength in the US-Israel technology corridor.

Partner with ambitious founders building category-winning companies. We believe great founders who understand execution, customer obsession, and operational excellence can build transformative companies. We provide capital, operational guidance, network access, and strategic partnership—not just funding.

Built for entrepreneurs, by entrepreneurs — NCV invests thematically in Next Coast markets (Austin, Midwest, Mountain West) at the Seed/Series A inflection point. They back glass-eating founders building category-defining companies in large markets, providing capital plus hands-on company building support via their 150+ expert network.

Early-stage investor in enterprise AI and complex B2B software backing hard-to-build, easy-to-scale products. We provide M&A coaching from former Google and Microsoft M&A heads who led 100+ technology acquisitions.

Backing experienced founders with deep domain conviction at the earliest stages. Fund genuine 'venture moments' — discrete inflection points where new capital validates novel hypotheses. Reject the factory model of venture; focus on capital efficiency and sound businesses.

Thesis-driven early-stage venture capital firm investing in visionary founders building transformative technologies in Vertical AI, Deep Tech, Healthcare, and Biotech. Focus on companies built on defensible data moats and novel technological breakthroughs solving fundamental problems. Emphasis on long-term value creation and partnership from day zero. Rapid decision-making (10-15 business days) combined with hands-on operational support. NPS score of 100 from portfolio founders.

Companies combining access, efficiency, quality, and data-driven insights represent the next generation of market leaders. We invest in European pre-seed and seed companies revolutionizing work, security, finance, gaming, and health through data-powered innovation.

Impact capital can address structural problems in America's $1 trillion education and workforce system. With 6 in 10 Americans holding less than bachelor's degrees and 40% of recent grads underemployed, we partner with founders removing barriers across the learner journey - from equitable access through career success.

The most enduring companies are created by founders willing to commercialize real science and scale real systems. We focus on hard tech at the intersection of computation and physical sciences—aerospace, biotech, energy, materials—where technical execution is the moat.

Healthcare has become unnecessarily complex and jargon-filled. Fresh perspectives from professionals outside healthcare can solve endemic problems. The fund invests in companies enabling physician independence, standardizing healthcare data and processes, leveraging patient communities, advancing patient-initiated diagnostics, combating fraud/waste, and serving as infrastructure for digital health entrepreneurs.

Data, cloud, and hardware advances will create unprecedented opportunities for great companies to be built. We invest in founders with big ideas and deep tech who are building infrastructure and value chains around data. Great people are the key to company success. We provide operational expertise, strategic guidance, and access to networks of mentors and international partners, particularly in China and Asia-Pacific.

Healthcare systems and climate-impacted industries are in generational transformation. We partner with mission-driven founders building enabling technologies—data, AI, software infrastructure—to accelerate this transition. Purpose and profit are inextricably linked.

Backing builders of the future of interactive entertainment. We invest across games, content, platforms, and ecosystem technologies with conviction that visionary founders are driving transformation in how we play, watch, create, and live.

Back passionate technology entrepreneurs building in Los Angeles with early capital, operational mentorship, and access to a network of 120+ experienced operators and executives. Focus on pre-seed stage with hands-on support through multiple fundraising rounds.

The capital before your story. We back experienced and repeat founders building Frontier Enterprise infrastructure — critical software solutions born from hands-dirty experience at top companies. We invest meaningful capital ($750K-$2M) as the first institutional check in pre-seed and seed rounds.

Invest from first principles and commit deeply to founders. TQ rejects thematic investing and backs exceptional founding teams with unique, compelling market visions — category creators rather than incremental improvers. They target companies that have raised less than $1.5M, positioning them as one of the first institutional checks.

We partner with bold builders of category-defining companies from Seed to Series F and beyond. Depth of commitment, depth of relationships, and depth of belief distinguish us. Complete immersion, authentic partnership, and unwavering conviction through market cycles.

We support forward-thinking founders crafting brands for the modern consumer. We invest across beauty & wellness, commerce technology, and B2B/enterprise, leveraging Unilever's global distribution, brand-building capabilities, and consumer insights.

The best founders want to be backed by other founders. Smaller funds run by founders perform best at pre-seed/seed stage. We operate as a decentralized fund-of-micro-funds empowering founder-GPs across global regions.

Invest in next-generation, values-led consumer brands at the critical first institutional capital round. Partner with authentic founders building conscientious consumer brands that align with cultural shifts toward wellness, transparency, and sustainability.

Cintrifuse Capital catalyzes Cincinnati's startup ecosystem by providing critical early-stage venture capital to local founders who face greater obstacles than coastal peers. The firm combines direct pre-seed/seed investments (including the Venture Velocity cohort program) with a fund-of-funds strategy investing in national VCs with Midwest alignment, creating a dual engine for ecosystem development and financial returns.

Founders backed by entrepreneurs. ZAKA bridges North American and CEE startup ecosystems, investing pre-seed to seed in Health & Biotech and Industrial Tech. The firm deploys institutional capital while leveraging operator networks to help European founders scale globally.

Investing in AI-powered companies that transform how consumers and businesses operate. Torch backs both the consumer-facing brand layer and the AI infrastructure enabling next-generation experiences, with particular depth in health & wellness, fintech, and consumer commerce.

Mission-driven companies solve big problems at scale while building durable competitive advantages. We back founders leveraging science & technology to build the Better Economy where people and planet thrive.

Application-layer AI and B2B marketplace businesses at Series A, focused on industries undergoing digitization and specialization. Conviction co-investors who do independent underwriting but never lead.

Overlooked founders in underserved geographies represent exceptional opportunities for category-leading companies. Panoramic combines serial entrepreneur credibility with institutional platform to back university-born and underrepresented founders from validation through scale.

Investing in world-class entrepreneurs advancing tech-enabled wellbeing. Building more emotionally intelligent companies that elevate how people live, lead, and connect with one another. Combines mission-driven impact with strong business fundamentals.

The era of transformational science is here. Life sciences and industrial markets are being reshaped by founders who move fast and build at the intersection of biology, chemistry, computation, and AI. This is a step-change in how science becomes solutions. We back bold founders who go beyond solving technical problems to redefine entire markets.

Make no little plans. Support revolutionary (not evolutionary) ideas that transform industries and benefit society. We partner with entrepreneurs solving massively multi-disciplinary problems at the intersection of AI, data, biotech, and deep tech. Our style of in-the-trenches venture capital doesn't scale—we make fewer than 10 investments per year so we have time to roll up our sleeves with every team we back.

Backs exceptional founders from pre-idea phase through seed. Fund IV ($185M) introduces Pre-Seed 2.0 with flexible check sizes ($50K-$2M), dedicated Founders-in-Residence program (including university track), and no forced fundraising timeline.

Invest with conviction in visionary, technical founders inventing the future with frontier computing technology. Focus on computing×real-world startups (techbio, climate, robotics, industrial infrastructure). Enforce strict rebuildability bar—won't invest if 3-5 Google engineers could recreate product in 3-12 months. Position against SaaS/consumer playbook; future venture outliers will be very different.

Software++ — mission-critical enterprise technology companies with differentiated tech and multi-layered monetization strategies beyond standard SaaS licensing. Seeks proprietary data, network effects, and workflow lock-in.

Partner with exceptional founders building technology companies with long-term growth potential capable of fundamentally shifting markets for the common good. Provide capital, operational expertise, board participation, and network access to support founder vision and company building.

Exceptional founders from overlooked backgrounds (women, people of color, LGBTQ+) can build unicorns if given capital, support, and belief at the earliest stage. We invest before institutional bias catches up, capturing outsized returns while advancing founder diversity.

Independent global investment platform backing capital-efficient, high-growth technology companies across Europe and North America. Multi-stage, multi-strategy approach from venture to pre-IPO. Transatlantic local teams provide unique advantage in bridging European and US growth.

Cota Capital invests in 'net new' technologies — visionary ideas that either were never before possible or solve problems that didn't exist before. Knowledge is the true capital. The firm backs early-stage enterprise technology companies where deep operational expertise, competitive intelligence, and network access can provide compounding advantage beyond the check.

Diverse industry experience enables superior pattern recognition about which founders can succeed. Operational support from founders-turned-investors is more valuable than just capital. Markets have seasons - breakthrough companies can emerge from unexpected places.

We back bold founders reshaping how we live, work, move, and connect. Our perspective is global. Our standard is excellence. Our purpose is to expand access, ownership, and opportunity at scale. We view the underfunding of women and founders of color as a market inefficiency.

Backing technical founders pre-pitch deck. Helen invests in engineers with technical depth, high learning rates, commercial instincts, and track records of pursuing ambitious long-term bets — before consensus forms around them.

Technical founders with data and technology advantages can build transformational businesses that redefine industries. We partner with experienced founders who combine technical depth with operational excellence and benefit from access to an elite network of Fortune 1000 executives and technical experts.

Hilariously early pre-seed/seed investing. We back hustlers at concept stage—fast, scrappy, first-principles founders who act before market consensus.

Back remarkable teams building startups at the intersection of Sustainability and Social Good, using the UN SDGs as guideposts. The firm's 'impact moat' framework holds that mission alignment creates durable competitive advantage, making impact and venture returns mutually reinforcing rather than exclusive.

Early-stage consumer startups leveraging technology to be cheaper and better, expanding market access. Back bold founders willing to take substantial personal risks and reshape categories. Focus on 99% economy democratizing access.

We invest in founders with deep technical expertise and a specific vision of the future. As former founders and company builders ourselves, we provide not just capital but steady partnership through early stages. We are contrarians who invest with conviction.

Invest in technology businesses with venture-pace growth potential, high margins, recurring revenue, and sustainable competitive advantage. Back exceptional founders who harbor passion to build great companies and are magnets for talent. Commit time, energy, network and hard work to portfolio company success, not just capital.

Expertise unlocks AI's full potential. We back technical founders who harness deep domain knowledge, apply novel AI applications, and push boundaries to create transformative breakthroughs in healthcare, life sciences, and enterprise.

We believe the greatest advancements of our lifetime will be the result of reprogramming chemistry and biology using creative technology platforms. We invest at the frontier of science, supporting founders re-architecting the world at a molecular level.

We invest in the future of food — backing game-changing early-stage ventures (Pre-Seed to Series A) that redefine how consumers achieve health and wellness across the entire food value chain: high-growth consumer brands, proprietary foodtech, next-gen commerce, and value-add digital technology. Fund III ($45M, 2024) emphasizes nutrition, sustainability, and digitization, with a thematic focus on food-as-medicine.

Investing in customer-obsessed founders redefining everyday experiences. We back founders at the earliest stage (pre-product/pre-revenue) with conviction, capital, and deep operational support including marketing, customer acquisition, and technology infrastructure.

Geek Ventures invests in bold, innovative, and brilliant immigrant entrepreneurs, pursuing high scalability and large total addressable markets (TAM) of $10 billion or more.

We back bold visionary leaders building innovative solutions across diverse sectors, with particular focus on AI applications, digital health, and enterprise software. We provide capital, operational mentorship, and network access to ensure long-term success.

Entrepreneurship is one of the most powerful engines for impact and value creation. Back founders with purpose, grit, and urgency building consequential companies solving significant problems in healthcare, fintech, and industrials. Lead first checks, stay in trenches, and scale together.

We are operators funding operators. We provide capital from our own personal wealth (no outside LPs) and offer hands-on operational advisory rather than board control. We believe the best venture support comes from those who have built and scaled companies themselves.

Democratizing health and wellness through disruptive consumer brands that combine purpose with profitability. Rocana backs authentic founders solving real wellness problems with products that deliver genuine health benefits while operating sustainably.

Pathbreaker invests in specialized engineering and product leaders solving critical global problems through emerging technologies (hardware and software). The fund believes AI, robotics, and computer vision will transform traditional industries over the coming decades. Pathbreaker focuses on companies tackling $100B+ problems at inception and pre-seed stages.

Group of founders, operators, and ecosystem builders investing in the next generation of Latin American startups. Sector-agnostic, founder-first approach with an 8-day decision commitment and deep operator network across the LATAM ecosystem.

Greater understanding leads to greater transformation. We partner with technical founders solving critical problems in enterprise software, fintech, infrastructure, and applied AI. First-principles thinking and operator-first approach to value creation.

The biggest companies of the century will be built solving the world's most pressing problems. We champion ambitious founders using technology to reshape civilization around climate, health, and inclusive capitalism.

Olive Tree Capital invests in groundbreaking technology and life sciences companies guided by the Golden Rule philosophy. As an evergreen vehicle without asset class limitations or holding period constraints, OTC can be a long-term partner to founders across any stage and geography.

We invest $250K+ into 'irrationally intense' founder CEOs and their teams. We believe early-stage companies need more than capital—they need operational mentorship, people operations expertise, and founder coaching. We provide comprehensive CEO feedback through a proprietary CEO 360 process, on-demand office hours, and real-time support via Slack and WhatsApp DMs.

Pre-seed fund investing in technical founders building developer-facing tools and infrastructure. Focused on curiosity, velocity of learning, and rapid building. Believe the world is shaped by unique insights at the intersection of art/culture and math/science.

Biology is the next frontier of technology. BABEL believes early-stage consumer biotech can solve macro problems (food security, climate, health) while delivering outsized returns. The best outcomes come from diverse, science-credentialed founder teams with deep domain expertise and commitment to sustainability and impact.

Clear invests in first-wave innovators in frontier technology — especially AI/ML, semiconductors, enterprise software, IT infrastructure, and security. We partner with magnetic founders tackling spectacular markets, providing seed capital, key connections, and company-building insights from operators who have built and scaled companies through IPOs.

Category-defining entrepreneurs building fundamental shifts that upend entire industries. Focus on disruptive business models in energy transition, healthcare, AI, and consumer. Thesis values human relationships and founder-centric partnerships over financial metrics alone.

Radian Capital partners with software-driven B2B companies at scale, providing capital and hands-on operational support. They concentrate on select companies and go deep with each, emphasizing sustainable growth over growth at all costs.

Partner with exceptional founders at the very inception of their entrepreneurial journey. Our proprietary data-driven technology identifies promising founders beyond immediate networks. We focus on teams with strong product sense and bottoms-up growth potential in data-driven software categories.

Disruptive innovation in work and education fuels human achievement. We partner with exceptional entrepreneurs who are business builders, deep domain experts, and capital efficient thinkers. We believe in long-term relationships over transactional investing, often partnering with founders across multiple ventures.

Concentrated capital for founders building what comes next. Amity leads at the earliest stages, investing in only 3-5 companies per year to provide deep partnership and meaningful support. 20% of their early-stage investments have reached $1B+ valuations (7 of 35 since 2016).

Delphi backs extraordinary founders at the bleeding edge of technology, operating at the intersection of crypto/blockchain and deep tech. Crypto is freedom technology enabling human coordination at scale without intermediaries. With AI and atomic breakthroughs, these forces will disintermediate legacy models and form foundations of civilizational change over the next decade.

By entrepreneurs for entrepreneurs — backing bold founders creating societal value through AI-native vertical software, momentum-driven market shifts, and Japanese founders scaling to the US. Operates both as a direct investor and as a venture builder co-creating startups from scratch.

The next decade will be defined by the addition of machine intelligence to software. Scale backs 'Cognitive Apps' — AI-powered applications that augment manual work and enable data-driven predictions — partnering with founders who can transition from founder-led to scalable go-to-market, accompanying them from Series A through IPO.

Early-stage innovation from founders backed by seasoned operators. We invest in disruptive technologies solving real problems at the intersection of scientific breakthroughs and practical execution. Our founders get patient capital, hands-on mentorship from 100+ years of combined experience, and access to our network for strategic growth.

Kinship Ventures backs 'TAM creators' — founders inventing new markets rather than competing in existing ones. Operating a two-pronged strategy: early conviction bets in category-defining founders and growth acceleration for companies approaching scale. From first check to IPO, they back founders who shape culture and build enduring companies.

By seeking entrepreneurs and funds who leverage modest resources to produce outsized returns, Lightship finds and develops remarkable talent while catalyzing emerging ecosystems. Impact and profit are simultaneously achievable.

Unearth, invest and grow startups into global leaders. iGlobe targets game-changing innovations at the frontier of deep tech — semiconductors, AI, quantum computing, and biotech — with a global orientation and a Singapore hub. Founded by Soo Boon Koh, Singapore's first female VC, the firm brings 25+ years of cross-border investing expertise and a top-quartile performance record.

Backs deep-tech founders who pair technical ambition with decisive execution. Invests in frontier technologies before they become mainstream across aerospace/defense, healthcare, biotech, enterprise AI, and deep hardware. Active partner model — regulatory introductions, customer connections, and strategic guidance through all company phases.

Founders with military backgrounds and demonstrated grit combined with differentiated dual-use technology create exceptional venture opportunities. We focus on pre-seed and seed-stage companies solving meaningful problems that make the country and allies safer while having strong commercial applications.

Backing dynamically developing enterprises with global aspirations at seed and early stage across Internet/SaaS, IoT/Hardware, Renewable Energy Sources, and Life Science (MedTech/BioTech). 4-14 year investment horizon with a patient capital approach through multiple fund vehicles.

African entrepreneurial talent is more widely dispersed across the continent than venture capital funding. We partner with visionary African and diaspora founders building global companies from Africa. We provide capital, operational guidance, and facilitate follow-on funding and expansion.

Invest in science-led consumer companies using a rigorous '12+ months to replicate' defensibility test. We back founders creating genuine technological moats by applying rigorous science to solve real consumer problems, with special focus on underrepresented founders (80% of portfolio).

Back great founders building category-defining technology companies at the earliest stages, especially those tackling complex business problems in ways once considered too hard to scale. Increasingly focused on AI-enabled companies unlocking previously impractical markets.

Be the most helpful investor. Back exceptional Australian founders building technology companies with strong founder-market fit and large addressable markets.

NTTVC backs founders with vision and energy to build transformative technology companies, particularly in enterprise technology, digital health, and AI/ML. The firm's unique structural advantage is its partnership with NTT — a Fortune 100 global IT services provider with 120,000 enterprise customers, $5B+ in annual tech resales, and a $22B systems integration business — giving portfolio companies extraordinary enterprise distribution and market validation channels.

Invest in emerging consumer brands that enrich the human experience. Partner with founders who understand authentic storytelling, disciplined capital deployment, and efficient unit economics. Look for brands positioned at the blurry edge—adjacent to massive incumbents but serving underserved customer demand.

BGV backs hands-on, cross-border enterprise AI startups operating under the Enterprise 5.0 framework — companies that combine intelligent machines with human ingenuity to drive leapfrog productivity improvements. They focus on vertical AI (industry-specific, proprietary data) and horizontal agentic platforms (cross-functional automation), with a strong preference for immigrant founders pursuing US go-to-market strategies from France, Israel, and India.

We invest in non-obvious founders with deep founder-market fit. Like a professional cycling leadout team, we protect and position founders while leveraging a curated network of operators from Apple, Stripe, and Nvidia to provide unusually broad support from day one. Over 85% of our portfolio is led by women or underrepresented minorities.

Back domain experts and technical founders building specialized AI solutions that solve real, specific industry problems. We pair deep technical AI foundations with industry knowledge to avoid commoditized horizontal tools.

We invest in technology companies that reduce friction at scale. Companies like Amazon and Uber fundamentally transformed industries by eliminating unnecessary complexity. We're looking for B2B software founders solving real enterprise problems, especially with AI.

Invest in companies that leverage creator networks and new forms of customer acquisition. We partner with founders building for consumer audiences who can tap into distribution through content creators, community, and influencer relationships. Our unique advantage is structural ties to Night Media, giving portfolio companies access to some of the biggest creators on the internet.

Madrona invests in people and ideas for the long run — backing visionary founders building transformational technology companies, with deep focus on applied AI across domain-specific applications, AI infrastructure, developer tools, enterprise software, and AI-enabled biotech. The firm serves as an active, full-stack partner providing capital plus recruiting, business development, and customer introductions.

Experienced Boston venture firm backing exceptional founders across enterprise software, consumer tech, AI, fintech, healthcare, and clean energy. Seeks to be first institutional capital, combining financial discipline with deep operational expertise and an extensive network. Emphasizes true long-term partnership — having navigated multiple economic cycles since 2001.

First institutional VC fund exclusively founded by former corporate VC leaders. Bridges traditional VC and corporate VC through Counter Club (750+ CVCs, $320B deployed). Invests in B2B SaaS solving nontrivial problems in large markets, providing founders with direct access to enterprise customers, strategic partners, and capital through the CVC network.

Technology that creates opportunity for the entire workforce through skills development, new work models, and portable benefits—excluding automation-first themes. We invest in companies that help humans adapt and thrive through economic transitions, with focus on rural and middle-skill America.

We back deeply technical founders solving hard problems with innovative technologies. Combining capital with go-to-market expertise and structured fellowships, we partner with founders who have authentic personal connections to their problems and bring novel technological approaches to market.

We invest in founders leading their first institutional venture round. Our mission is to catalyze transformation in Latin America by partnering with the region's top entrepreneurs. Together, we create cycles of innovation, empowerment and change. We believe in long-term partnerships and hands-on support.

Asymmetric invests in exceptional founders disrupting legacy industries through Vertical Software, Healthcare IT & Services, and SMB Consolidations (rollups). The firm targets 20% ownership as lead, writing $2-10M checks from Pre-seed through Series A. Founded by former PE investors and operators who provide deep operational, strategic, and financial partnership beyond capital.

Quantitative, data-driven investing at the Pre-VC stage. We invest in capital-efficient technology startups with $5K–$30K+ MRR at $1.5M–$4M valuations. Fast decisions (one week), no gatekeepers, no BS.

Phoenix Court partners with exceptional founders from pre-seed through public markets and beyond. The firm operates as a multi-stage, multi-fund group — LocalGlobe (seed), Latitude (growth), Solar (late-stage), and Basecamp (emerging managers) — built on the conviction that the best companies grow big not just in private markets but across their full lifecycle. Founded on purpose: 10% of profits and 2% of carry go to Phoenix Court Works, which is transitioning to the single largest shareholder in the firm.

We identify and scale proven product-market-fit technology companies for global expansion and IPO readiness. Our partnership combines world-class macro research analysis with hands-on operational expertise from experienced technology leaders who have built and scaled billion-dollar companies.

Remedy Product Studio is an AI-native software development firm with a CVC arm; we partner with and selectively invest in the companies we help build. We embed alongside your team and measure success by your outcomes: time to market, ROI, and business impact. We aim to be the most incentive-aligned, least dilutive partner on your cap table. Our partners have raised over $1B, cut tech costs by 2.5x, and achieved multiple exits. Ask us about our AI Orchestration Pods.

Georgian invests in market-leading B2B software companies across the AI technology stack—from infrastructure and developer tools to enterprise applications and cybersecurity. They pair growth-stage capital with an in-house AI Lab of 20+ ML engineers who embed with portfolio companies post-investment.

We invest in early-stage consumer and B2B technologies that meaningfully enhance personal and professional lives. We back application-layer software with consumer-grade UX that people actually use every day. Our focus: Wellbeing (health & vitality, life optimization, community & social) and Productivity (intelligent workflows, creative enablement, professional augmentation).

Invest where generational fractures create outsized market opportunities. Focus on health, wealth, and upward mobility through backing diverse teams and women-led companies overlooked by mainstream VC. Partner with founders building for Gen Z and solving structural system failures.

MS&AD Ventures partners with visionary entrepreneurs to create innovative solutions across insurance, financial services, healthcare, and sustainability. Backed by the 5th largest global insurance conglomerate, they bring capital plus global distribution across 47 countries. They move fast (2-week decisions), focus on partnerships over ownership, and help companies scale internationally.

Wave Ventures backs Europe's most exceptional Gen Z founders at the earliest stage — angel and pre-seed — in the Nordics and Baltics. We invest before other VCs identify these founders, leveraging a rotating team of top university students embedded in Helsinki, Stockholm, and Tallinn startup ecosystems. We believe the most impactful companies of the next generation will emerge from this region.

Back underestimated founders with something to prove who are disrupting large markets. Emphasizes geographic arbitrage in emerging markets (Africa, LATAM, Asia) where founder quality is exceptional but capital access is limited.

Back nerds and pioneers tackling tough problems that matter across European tech. Support founders building hard-to-build but essential products. Real partners for expert founders.

Capital F invests in technology for the $15 Trillion female economy. We are operators who invest, not VCs—capitalizing on 50 years of combined C-level operating experience to back top founders building in Health, AI, and Digital Commerce with B2B SaaS and B2C technology.

Great products change the world. We fund the people who build them. The Product Alpha Effect™ uses signals from 600,000 product leaders to identify outlier companies at the Discovery Stage before the market recognizes them.

Investing in the next generation of badass founders. The firm identifies founders whose backgrounds uniquely position them to create transformative businesses in rapidly growing markets that are often overlooked by mainstream venture capital. Focus on the 'Chingona Factor': market fluency, lived experience, and sheer will.

Community-driven VC led by active operators who simultaneously build and invest. Best support for founders comes from operators understanding current market challenges firsthand, not just history. Invest in category-defining technology companies.

Founder-centric VC backing bold, tech-enabled entrepreneurs transforming industries across Spanish-speaking Latin America. Invests from Seed through pre-IPO with deep operational support including networks, talent, and strategic partnerships. Uses proprietary data and AI to source and evaluate deals.

Exceptional founders exist everywhere, not just Silicon Valley. By backing underrepresented and overlooked founders solving real market problems outside major tech hubs, we access high-conviction founder pools and less competitive deal spaces, driving outsized returns while expanding venture capital access.

Founders with genuine conviction solving important problems, backed by unfair advantages and exceptional drive. We provide capital, operational expertise, and access to 100+ world-class startup operators. Our value is in the people on your cap table and the hands-on support—not just the checks.

Invest in people over product at the earliest stage of the entrepreneurial journey. Write the first institutional check for the most promising software and hardware companies. Focus on long-term relationships with founders.

Early-stage Latin American entrepreneurs solving critical healthcare, environmental, and societal challenges using science and technology. We provide capital, Silicon Valley networks, and operational expertise to build transformational companies.

EPIC Ventures backs early-stage technology companies building in the information economy, with a focus on enterprise SaaS, healthcare technology, cybersecurity, and future of work. The firm believes the best way to build lasting companies is through genuine partnership with founders — providing capital, strategic guidance, operational expertise, and deep network access. Founded in 1994, EPIC helped build the Utah tech ecosystem and continues to be the foundational VC of the Mountain West.

Overlooked markets where distribution advantage compounds. Founders with deep domain empathy build durable moats. B2B software rebuilding industries through core workflows, data connectivity, and embedded intelligence.

We invest in traditionally overlooked and untapped consumer technology opportunities across the future of how we care, play, and live. Demographic shifts (aging population, female wealth, cultural diversity) create massive new markets. We don't chase hype—we invest in what should exist.

We back bold, ambitious, and resilient founders driving breakthrough innovations in HealthTech, CleanTech, and AgriFoodTech. Female-led and gender-mixed teams deliver superior returns and drive meaningful impact. Over five decades of combined experience navigating financial cycles enables us to partner authentically with founders, providing not just capital but strategic guidance and operational support.

Mundi backs bold, purpose-driven founders building technology companies at the intersection of deep tech and critical global challenges. Core thesis: Europe has world-class talent and ecosystem but suffers from a scale-up funding gap at growth stages. Kembara fund (€750M) bridges this by providing Series B/C growth capital to European deep tech and climate champions.

First institutional check for technical founders building the future of B2B software. We provide capital and hands-on platform support at the pre-seed stage.

We back founders venturing beyond to build transformational companies that create positive, enduring change. Applied AI and global resilience are fundamental forces reshaping industries.

We are long-term business partners to founders. We operate as an investment partnership focused on founders building category-defining African technology companies, with tight founder-investor-LP alignment and deep operational support.

We partner with high-integrity, problem-obsessed, wildly interesting founders at early stage. We are long-term investors, backing founders at inception and continuing to invest until IPO. We have a single mandate: to help fledgling companies navigate the challenges of building generational businesses. Rather than being a traditional write-a-check fund, we provide full-stack partnership: capital, operational support, strategic introductions, recruiting, business development, and fundraising support.

Profit and purpose can form a virtuous cycle. We champion founders driving advanced energy, resource innovation, and economic opportunity. We believe that addressing humanity's biggest challenges requires innovative, scalable, profitable solutions. We help seed-stage startups bridge tech and deep-tech, venture and values-aligned investing.

Eka backs founders creating positive system change across three consumer-led mega trends: Life (access and affordability in essentials), Health (reactive to preventative healthcare), and Sustainability (decarbonization in consumer industries). The firm holds that impact and financial returns reinforce rather than oppose each other.

The world's most successful B2B software companies require presence and success in both North America and Europe. Frontline specializes in facilitating frictionless transatlantic expansion, supporting founders with global ambition through a dual-fund strategy optimized for international growth.

Montage Ventures aims to support radical thinkers who are bringing new ideas and platforms to foster change within the financial services, commerce and health sectors, leveraging AI as a key transformative agent.

We back MIT founders building deep-tech companies with defensible science or engineering advantages. We support the transition from researcher to founder, providing both capital ($500K-$5M) and operational support through the MIT ecosystem.

Founders building the possibly impossible deserve capital plus marketing support. Great technology combined with exceptional storytelling and narrative development creates world-changing moonshots. We provide both the capital and the story-telling expertise to help founders achieve escape velocity.

Investing in tomorrow's needs—promoting financial inclusion and social security for underserved communities through early-stage fintech, insurtech, and Islamic fintech. We enhance entrepreneurs' capacity to build sustainable, adaptable businesses and provide market access support, ESG mentoring, and operational advisory alongside capital.

Technology can have a highly disruptive impact on society. We back founders on the forefront of innovation with clear vision towards positive change, leveraging domain expertise to ensure value creation. Founder-first approach with operational support.

NVP backs early-stage founders using vertical AI and enterprise software to modernize under-digitized legacy industries, especially healthcare, industrials, financial services, workforce management, commerce enablement, legal workflows, and sales and marketing operations.

We invest in mission-critical infrastructure serving women and working families. Many essential systems have been dismissed as too complex or too human to solve, but technology and AI advances make transformation possible. This is a $1 trillion opportunity and generational economic growth driver.

The biggest constraint for early-stage companies is not capital—it's building a world-class team. We provide capital plus measurable talent sourcing, recruitment excellence, and team-building advisory. We have proven ability to reach candidates not reachable by recruiters or founders, and commit to specific hiring targets for each portfolio company.

Backs bold founders in technology and healthcare building companies that will define the future of their industries. Two practice areas: Enterprise/AI (AI infrastructure, frontier systems, cybersecurity, defense, fintech, developer tools) and Healthcare/Life Sciences (digital health, therapeutics, genomics, health system modernization). Deep partnership model, long-term patient capital approach across market cycles since 1969.

Back incredible founders with strong domain knowledge tackling real, durable problems with high growth potential in large and growing markets. Specialty in B2B software and automation for legacy industries — financial services, manufacturing, insurance.

AI Eats Software. Over the next decade, virtually every bit of software will be replaced by artificial intelligence. We invest in founders and entrepreneurs who understand the transformational power of AI and are building solutions that reshape how we live, work, and play.

Big things start small. We invest at seed stage and see potential where others don't. We believe in your vision for your company's future, not as it exists today. We think in decades, not days, committing to walk the entire journey with founders to build iconic companies. We share Antipodean ingenuity with the world.

Supply Change Capital invests at the intersection of food, climate, and culture. We back early-stage technology transforming the food supply chain's foundational infrastructure - from supply chain resilience and logistics to health/nutrition innovation and labor automation. We believe the global food system ($10T industry) is least modernized sector globally, requiring urgent technological transformation to address climate impact (1/3 of GHG emissions), health crises (50%+ with diet-related chronic disease), and labor equity. We invest with dual lenses: climate impact (emissions reduction, soil health, biodiversity) and culture (supporting diverse founders who deliver 30% higher returns despite underinvestment). As former operators, we partner with founders not just with capital but operational expertise, impact metrics frameworks, and access to extensive advisor network of industry veterans.

Impact and profit are inseparable. We back visionary founders solving humanity's toughest problems in healthcare, AI, robotics, defense, and automation. We measure success in lives saved as well as returns.

The world is awash with regulation. Early-stage founders in regulated sectors need venture capital combined with policy expertise and market access support. We bridge the gap between technology innovation and regulatory navigation.

The next generation of breakout companies will be built by underestimated founders solving big problems for the 99%. Founders who intuitively understand their end users – because they've lived through the same broken systems – have a natural competitive advantage. BBG Ventures focuses on 'polycultural' founders: those who understand intersectional, multi-generational, and underserved markets. These founders will drive impactful and valuable companies through AI democratization.

CEE founders (Polish, Ukrainian, Romanian, etc.) are building the next generation of global software companies. We partner with experienced operators who combine deep industry expertise with serial entrepreneurship. Geographic arbitrage: exceptional technical talent in CEE with lower burn rates, global ambition. We provide early capital plus connections to Silicon Valley for follow-on funding (80% of portfolio follow-ons from SV/Europe/Asia). Goal: $500M+ exits in 8-10 years.

Seed capital is the foundational layer in building enduring companies. We back bold, gritty founders applying AI and machine intelligence to solve the world's toughest challenges in enterprise and industrial sectors. By end of decade, software + hardware + AI will drive ubiquitous automation in every industry. We partner with visionary founders tackling hard technical problems in regulated, complex domains.

Back extraordinary entrepreneurs throughout the company-building lifecycle from seed to IPO. Combine venture capital expertise with BCG management consulting to accelerate value creation. Support founders with capital, strategic guidance, and access to global networks.

AI-native quant VC backing seed-stage founders with speed and precision. The world's first AI-only fund uses proprietary machine learning models and a University of Oxford research partnership to identify exceptional founders building category-defining AI products. Vela's AI Suite analyzes 300+ early-stage companies weekly; their models demonstrate 10-20x improvement over baseline success prediction rates.

Founders who intentionally pick hard problems outperform. The founders we back don't shrink in the face of a tough challenge, and it's this courage that is the root of outperformance. Picking hard problems attracts exceptional early talent and the most ambitious capital partners. We back technically ambitious founders at inception — before markets are well-defined or consensus has formed.

Back outlier founders who break the rules, mold, glass, cycle, and internet — wherever they are. True generalist fund focused on pre-seed and seed across US and Canada, with emphasis on underserved markets (PNW, TX, Canada). Founder quality above all else.

N49P partners with visionary Canadian founders to transform markets at inception, pre-seed, and early seed stages. They back founders who prioritize speed and execution over traditional credentials, with clear vision and the ability to recruit exceptional teams.

Deep tech startups at the edge of what is possible solve critical human and planetary health problems. SOSV backs founders combining scientific rigor with entrepreneurial grit, providing not just capital but access to specialized labs, manufacturing, and global expertise networks.

Find strong, ambitious founders working on what we believe to be game-changing technology, and put in the hard work to add value every step of the way. We invest in founders with robust information asymmetries developing core technology innovations with the potential to disrupt and redefine industries.

Back great founders building category-defining companies, regardless of stage. We provide patient capital, hands-on operational support, and deep network access to enable breakout success.

UX is the new defensibility. As AI commoditizes the cost of building software, the competitive moat shifts to user experience and human-AI interaction design. FoundersEdge backs experienced, multi-time founders building AI-native software for legacy industries.

University-based founders are underestimated and underfunded. Honors Fund writes the first institutional check — $250K SAFE at $2M post-money — into student and faculty software startups, providing capital, mentorship, and network access to accelerate the next generation of founders.

Venture capital can achieve both financial returns and positive social impact. Founders with lived experience in underrepresented communities identify rapidly-scalable solutions others overlook. Diversity and inclusive business practices drive superior returns and competitive advantage.

We refuse to compromise between doing good and delivering strong financial and commercial returns. Portfolio companies gain access to TELUS's commercial networks, data-rich platforms, and deep expertise across agriculture, health, and connectivity giving them a unique edge as they scale.

Early investors and long-term partners. We back exceptional founders solving real problems across sectors. When you hit a bump in the road, we're there solving problems alongside you with operational expertise and network leverage.

Africa's future prosperity depends on technological innovation across foundational sectors. Brilliant entrepreneurs applying technology to solve Africa's most pressing problems build world-class businesses while generating exceptional returns. Commercial rigor combined with social impact creates sustainable value.

We back founders who are innovating the products, services and software in our everyday lives. We believe that the entrepreneurs who have intimately felt the problem they are solving will create the things consumers want the most.

Extraordinary companies are built by driven founders whose mission to improve the health of people and planet is inseparable from their product. We partner with technical founders building technology solutions to the world's most important challenges across climate, health, biotech, and enabling technologies.

Build category-defining technology businesses that deliver strong investment returns while addressing pressing business challenges. Leverage Fortune 500 parent (MassMutual) assets including real estate portfolios, renewable energy assets, and capital networks.

Young student founders with ambitious vision and strong execution ability can build transformational companies. Providing accessible capital plus institutional support at the earliest stage unlocks value that might otherwise remain invisible to traditional VC. University students represent a unique cohort—bright, ambitious, and unconstrained by traditional career paths.

Nordic-focused VC providing global access and local support for the region's most daring tech pioneers. We back transformative companies across gaming, AI, software infrastructure, and emerging technologies with founders who have global ambitions and shipping experience.

Social impact companies are undervalued at the earliest stages when metrics are unclear. We invest very early in mission-driven founders tackling the world's hardest problems, supporting them until they're attractive to top-tier VCs. 12-15 exceptional entrepreneurs can solve the largest global challenges.

We invest in relentlessly resourceful founders solving real problems. Capital is just the beginning - we provide connected access to 400+ founders, operators, and luminary investors from the world's greatest tech companies. We invest at Day 0, pre-revenue, across sectors and geographies.

The entrepreneurial journey from zero to one is isolating and difficult. By becoming an extension of portfolio founders' teams, we can build the next generation of successful B2B SaaS companies. We invest in founders first, companies second. Technology should be human-centered, founder-first, and focused on solving real market problems.

Gender-diverse teams produce superior returns on equity. We fund exceptional women-led startups where women hold meaningful operating C-suite roles and own substantial equity. Research shows companies with diverse female leadership are 39% more likely to be above-average profitable, 30% more likely to outperform, and 20% more likely to improve business outcomes.

Back outlier founders with unconventional ambition and deep-rooted urgency operating outside conventional wisdom. We believe the best companies are built by rare entrepreneurs who can filter out 95% of typical VC advice and construct exceptional talent and culture.

Investing at the intersection of for-profit and for-good. Companies that make the world better AND deliver strong financial returns. The Villain Test ensures both impact and profit alignment.

Expand the AI ecosystem by backing technology visionaries solving complex problems to reshape our world. Focus on game changers and market makers in AI, robotics, biotech, autonomous vehicles, and applied AI. Leverage NVIDIA's unique position as GPU infrastructure leader to identify and support companies that will drive adoption of NVIDIA technology.

Radically simplify complex, regulated categories while delivering consumer-grade experiences. Back cult brand consumer companies with intense customer affinity built through innovative products and values-driven models. Focus on direct-to-consumer, personalization, and marketplace models across consumer, enterprise, and healthcare.

Back force-of-nature founders at pre-seed and seed stages building B2B software companies. Primary value-add is hands-on recruiting (150+ candidate sourcing per role) and GTM development—not board seats or traditional governance.

Fund companies that help people live longer and live better through science and technology. We support exceptional technical founders solving real health and happiness problems with scientific rigor and consumer appeal. Our data-driven methodology and proprietary ML platform identify outsize return potential in complex early-stage companies.

Invest in century-defining technologies and companies. Focus on infrastructure-oriented, cross-vertical applied AI for physical-world and life-science problems, with deep healthcare systems expertise. Transform industries through foundational technology breakthroughs.

We invest in co-founding teams from research labs solving the most pressing challenges in science and technology. The most important aspect of deep tech companies is the founding team—we invest in technical founders with entrepreneurial spirit, not just ideas. We provide patient capital, deep technical mentorship, and access to UC Berkeley's innovation ecosystem and corporate networks.

We are extremely early in translating powerful AI models into products that transform industries. Startups have the speed and unruliness to build transformative AI-native companies; big companies are too slow. There has never been a better time to start a startup.

Great entrepreneurs exist everywhere. Women, BIPOC, LGBTQ+, and veteran founders have access to exceptional capital and mentorship. We combine venture funding with deep mentorship to unlock value in underserved founder populations.

Backing 'Venture Scientists' — PhD-trained technical founders applying rigorous scientific methodology to build transformative companies from fundamental research. Focus on deep tech and life sciences areas that address climate change, resource scarcity, and healthcare accessibility. Targets university spinouts and science-led startups in areas that are difficult to diligence for generalist investors.

Funding the future of risk for the human endeavor. Munich Re Ventures invests in technologies and business models tackling the biggest risks facing the world, operating at the intersection of technology, venture capital, and the insurance industry.

The most valuable companies of our time will be the ones solving humanity's biggest problems across planetary health, human health, and economic health. We back exceptional founders building breakthrough solutions that create both financial returns and positive impact.

Early-stage business technology companies are strongest when unified within a thriving ecosystem. We invest in companies changing how the world does business through AI/ML, cybersecurity, fintech, and SaaS+ (vertical SaaS platforms layering embedded fintech to multiply revenue).

Help founders succeed by combining capital ($120K-$250K), intensive mentorship (3-month program), and access to a powerful global network of 1,500+ mentors. We invest in founders at the earliest stage with conviction and vision, regardless of sector or geography. Our #GiveFirst philosophy drives us to help without expecting immediate return.

Mantis invests opportunistically in Seed and Series A technology-enabled startups, leveraging deep social capital across tech, media, entertainment, and finance to provide unmatched GTM support. The firm is founder-obsessed and differentiates through celebrity network access, customer introductions, talent acquisition help, and brand amplification.

Identify and partner with visionary entrepreneurs building category-creating companies that unlock entirely new addressable markets. Focus on 'silent suffering' where customers tolerate suboptimal solutions. Use AI, data, and behavioral science to identify non-obvious market opportunities and founder-market fit.

Emergence invests in early-stage B2B software companies that will define the next era of enterprise technology. Founded in 2003 as the original cloud/SaaS-focused VC firm, they have pioneered investing through technology transitions: horizontal SaaS (Salesforce, Zoom), vertical SaaS (Veeva, Doximity), and now AI-native services — companies that sell outcomes rather than software, powered by AI that compounds competitive advantage over time.

Partner with extraordinary founders building the next generation of iconic Latin American technology companies. Invest in any tech-enabled sector where innovation can drive significant disruption. Bring not just capital but deep operational expertise as former MercadoLibre executives and entrepreneurs.

We invest in brilliant people who bring ideas that matter to life. We focus on AI-native founders building companies with strong founder-product fit, aligned on mission and meaning, seeking creative freedom and psychological safety. Great companies are built by diverse teams supported and empowered to be maximally creative.

Back technology founders solving foundational and transformational problems across Africa and MENA. Focus on underserved markets with significant TAM. Support entrepreneurs demonstrating grit, creativity, growth mindset, and conviction. Combine global capital markets access with deep local operational expertise.

Reshape the Nasdaq by investing in venture capital's biggest blind spots. Back exceptional founders historically overlooked by traditional VC due to demographic factors or non-traditional backgrounds. Leverage proprietary Female Founders Alliance (5,000+ members) as deal flow engine to surface underestimated founders across multiple archetypes.

Fund technology companies built by an alpha pack of founders creating pathways to wealth, mobility, and long-term economic resilience. Focus on diverse and underrepresented founders solving big, hairy problems for families and businesses.

Early-stage founders using AI and frontier technology to reinvent enterprise and security markets. We seek technical founders who deeply understand their problem domain, have operating experience at scale, and are committed to responsible AI development. We provide not just capital but hands-on operational support through our Building Partners model.

Big markets with outdated incumbents. We invest at the intersection of venture capital and media, leveraging our podcast platform (20+ million annual listeners) and founder network to source, support, and amplify portfolio companies. We target companies with strong market dynamics and clear disruption paths regardless of sector.

Permanent balance-sheet investor backing highly defensible, category-defining, mission-driven companies solving the world's biggest problems. Focus on founders transforming legacy industries with emphasis on diversity, equity, and inclusion.

Exceptional technology companies can be built anywhere—US, Israel, or Europe. We partner with experienced founders to provide capital, US market expertise, and global networks to help them scale internationally.

Back focused founders solving real problems in markets they understand deeply, with clarity, discipline, and drive. Seek companies with motivated teams, strong product vision, scalable business models, and large addressable markets.

Underrepresented founders from Black, Latino, and Indigenous communities represent the best underactivated market for technology venture capital. Generations of adversity have made these entrepreneurs particularly resilient and innovative. We provide capital, operational support, training, and networks to help these founders build transformational technology companies.

Early-stage fintech, B2B software, enterprise SaaS, digital infrastructure, payments, embedded finance, and AI workflow infrastructure companies across the US, UK, Europe, and Israel.

Back founders with an athlete-like commitment to the long game across Health (longevity, fertility, performance), Future of Work (AI-native productivity, developer tools), and Global Mobility (immigration, cross-border infrastructure). Invest at pre-seed when post-money valuations are under $10M.

Ambitious founders solving fundamental problems across major industries. The next generation of transformational companies will be built on modern AI, secure infrastructure, and efficient commerce. We partner with technical founders with operator experience and compelling narratives.

Back the most ambitious founders from Central and Eastern Europe at the very earliest stages — before product, before revenue. CEE is a world-class talent pool producing generational companies, and Credo's edge is local knowledge and 17+ years of founder relationships.

Support passionate founders forging the future. Invest in seed and early-stage companies with unique ideas that have potential to reinvent entire industries. Focus on frontier technologies that make the world better and don't prey on human frailty.

Upstate New York can be the region for high-growth startup success. We provide mentorship, capital, and connections to fuel innovation, job creation, and regional economic growth. Founders aligned with community impact, job creation, and solving regional challenges are ideal.

Top-performing SaaS venture fund that identifies exceptional founding talent at the earliest stages and takes an active role in their growth — particularly in scaling go-to-market and sales teams. Prioritizes founding team potential over traction or revenue metrics.

Back entrepreneurs who think laterally and experiment across disciplines. We seek founders with multidisciplinary abilities who will become more insightful innovators. We value creative problem-solving, intellectual curiosity, and the ability to synthesize insights across fields.

Moonshot founders with differentiated industry expertise, outsized ambition, and demonstrated tenacity transform traditional industries. The best founders come from diverse backgrounds, not Silicon Valley networks. We back founders before they have product, customers, or revenue.

Partners with exceptional founders building game-changing companies at the intersection of technology, industry, and culture. Focus on sectors where deep network and experience can bend the risk curve.

We partner with experienced, technical founders to build category-leading companies in Vertical AI, Fintech, and Healthcare. We believe go-to-market execution and distribution are the real momentum builders in today's market where technical barriers to entry have lowered. We provide specific, measurable value tied to revenue, particularly helping founders land their first enterprise customers.

Invest in visionary founders from Latinx and diverse backgrounds building disruptive tech solutions. Capitalize on demographic trends and founder quality in systematically underestimated segments. Create alpha through early-mover advantage in overlooked founder networks.

The best way to find and support AI companies is to be one ourselves. We back independent thinkers building real systems before consensus forms, partnering as radical learning partners from day one.

Pattern-breaking founders solving real problems generate breakthrough solutions. We believe the best companies come from overlooked founders outside Silicon Valley, regardless of pedigree or traditional markers of success.

Women-led fund focused on healthcare infrastructure—middleware, payments, clinical trials, and data architecture—thesis-driven, GTM-heavy partner offering hands-on commercialization support for technical founders scaling into payer and provider markets.

Women founders represent an overlooked asset class that delivers superior returns. Women-founded companies earn 26% more for investors, yet receive only 2% of venture funding. We invest exclusively in women-founded companies, providing capital, network access, and operational support to drive transformative change.

We supercharge growth in breakout companies, converting momentum into market dominance. We invest exclusively at Series B and beyond in companies that have achieved product-market fit and are ready to scale from millions to hundreds of millions in revenue.

Backing ambitious Baltic founders who can build global-scale businesses. We invest in teams with proven grit and determination. Our main investment criteria is team and whether they have the grit to succeed. We provide €100-750K in pre-seed and seed capital, hands-on support, and deep networks of founders, angels, and later-stage investors.

Shine partners with creative, convincing, relentless entrepreneurs to build iconic businesses. They are lateralists - using non-linear logic to identify innovation at the intersections of technology, markets, and culture. The firm invests thematically in areas shaped by four trends: Great Expectations (demand for quality), Merging Digital/Physical (computing power), Reimagining Security (infrastructure/identity), and Reestablishing Meaning (community/belonging).

Invest in companies addressing fundamental societal needs. Provide Talent/Capital/Attention platform via in-house content and advisory network. Mission-driven investments with specialized expertise in healthcare, climate, robotics, and deep tech.

Consumer investing requires a fundamentally new playbook built for an omni-channel world where technology, data, and brand storytelling are deeply intertwined. Coefficient identifies growth-stage consumer businesses in established categories undergoing structural change, using proprietary data and an annual Consumer Trends Report to find category-defining brands early. Strategy centers on backing brands positioned for strategic exits to major CPG acquirers.

The world is missing out on innovative companies by not investing more heavily in women and diverse entrepreneurs. We back the next generation of winners - founders with unreasonable standards, relentless conviction, and the drive to build generational companies. We're committed to changing the face of entrepreneurship and creating generational wealth for people of color and women.

Depth-first venture investing through mastery in specific domains. We partner with bold builders challenging industry conventions, backing founders with technical depth and conviction to build enduring $1B+ companies. Complete immersion creates enduring companies.

Brings private equity rigor to early-stage venture with a Capital + Talent + Growth model. Invests in Vertical SaaS, AI, Cybersecurity, and Health Tech from Pre-Seed to Series A, combining capital with in-house executive search (Roo Search, 23,000+ candidates, 600+ placements) and operational playbooks (Roo Growth). Targets companies bridging MVP to scale.

VSC Ventures backs founders using AI to fix data, labor, and safety challenges in Dirty, Dusty, Dangerous industries. They combine capital with integrated PR/media infrastructure to help portfolio companies build narrative and distribution as a competitive moat.

The adverbs matter just as much as the verbs — how you build is as important as what you build. Exceptional people and character transform ideas into industry-shaping companies. We back extraordinary founders at pre-seed and seed who have unique insight into their market and the operational excellence to build in the right way.

Back 'crazy dreamers' — founders with exceptional tenacity, ambition, and vision who are building transformative companies. BASS serves as the 'bassist' providing foundational support: capital, operational resources, global cloud credits, and talent. Focus on AI software, physical AI, and fashion & beauty in 2025.

User-owned technology empowered by distributed systems and cryptography enables people to reclaim control from intermediaries. We invest in systems that reduce reliance on centralized institutions and give users control, privacy, and access to global markets.

Partner with visionary founders to turn bold ambitions into world-changing breakthroughs in life sciences, technology, healthtech, and crypto. Distinctive 'technical-risk-yes, regulatory-risk-no' filter ensures clear pathways to success.

Tech-enabled businesses built for and by people in marginalized communities create new frameworks of ownership and opportunity. Traditional VCs miss billion-dollar markets in overlooked communities.

Early-stage venture capital firm led by experienced CEO providing pre-seed and seed capital to technology-enabled startups, emphasizing leadership development, operational mentorship, and building sustainable companies from the ground up.

B2B AI/ML software companies disrupting legacy industries (real estate, finance, insurance, logistics). We provide capital plus hands-on operational support.